The global clinical trial supplies market was valued at USD 2.58 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Several key factors contribute to this growth, including the globalization of clinical trials and the increasing number of biologic and biosimilar drugs under development. As biologics and biosimilars become a larger portion...